Page 73 - BH-2-1
P. 73

Brain & Heart                                                     Mesenchymal cell therapy for heart disease



               ischemic cardiomyopathy. Am J Cardiol. 2013;112(2):217-225.  46.  Poomani MS, Mariappan I, Perumal R, Regurajan R,
                                                                  Muthan K, Subramanian V. Mesenchymal stem cell (MSCs)
               doi: 10.1016/j.amjcard.2013.03.021
                                                                  therapy for ischemic heart disease: A promising frontier.
            42.  Zhang  M, Mal N,  Kiedrowski  M,  et al.  SDF‐1  expression   Glob Heart. 2022;17(1):19.
               by  mesenchymal  stem  cells  results  in  trophic  support  of
               cardiac myocytes after myocardial infarction.  FASEB J.      doi: 10.5334/gh.1098
               2007;21(12):3197-3207.                          47.  Li B, Zeng Q, Wang H, et al. Adipose tissue stromal cells
                                                                  transplantation in rats of acute myocardial infarction. Coron
               doi: 10.1096/fj.06-6558com
                                                                  Artery Dis. 2007;18(3):221-227.
            43.  Karpov AA, Udalova DV, Pliss MG, Galagudza MM. Can      doi: 10.1097/MCA.0b013e32801235da
               the outcomes of mesenchymal stem cell-based therapy for
               myocardial infarction be improved? Providing weapons and   48.  Makkar RR, Price MJ, Lill M, et al. Intramyocardial injection
               armour to cells. Cell Prolif. 2017;50(2):e12316.   of allogenic bone marrow-derived mesenchymal stem cells
                                                                  without immunosuppression preserves cardiac function
               doi: 10.1111/cpr.12316
                                                                  in a porcine model of myocardial infarction. J Cardiovasc
            44.  Pankajakshan D, Agrawal DK. Mesenchymal stem cell   Pharmacol Ther. 2005;10(4):225-233.
               paracrine factors in  vascular repair and  regeneration.      doi: 10.1177/107424840501000403
               J Biomed Technol Res. 2014;1(1).
                                                               49.  Bobi J, Solanes N, Fernández‐Jiménez R, et al. Intracoronary
               doi: 10.19104/jbtr.2014.107
                                                                  administration of allogeneic adipose tissue-derived
            45.  Bagno L, Hatzistergos KE, Balkan W, Hare JM. Mesenchymal   mesenchymal stem cells improves myocardial perfusion but
               stem cell-based therapy for cardiovascular disease: Progress   not left ventricle function, in a translational model of acute
               and challenges. Mol Ther. 2018;26(7):1610-1623.    myocardial infarction. J Am Heart Assoc. 2017;6(5):e005771.
               doi: 10.1016/j.ymthe.2018.05.009                   doi: 10.1161/JAHA.117.005771
















































            Volume 2 Issue 1 (2024)                         7                         https://doi.org/10.36922/bh.2065
   68   69   70   71   72   73   74   75   76   77   78